Regarding KEGG pathway enrichment, the low expression group of SLC3A2 exhibited significant enrichment in Serotonergic synapse, GABAergic synapse, Neuroactive ligand-receptor interaction, and Nicotine addiction (Fig. 4A-B, Table S1). The gene discussed is SLC3A2; the disease is nicotine dependence.